Foresight Diagnostics is an innovative, early-stage molecular diagnostics company based in Boulder, Colorado, focused on developing non-invasive cancer detection technologies. With a strong foundation in cell-free DNA based liquid biopsy tests, the company leverages proprietary methods developed at Stanford University to enable earlier detection of tumors, thereby enhancing personalized cancer treatment strategies. Foresight Diagnostics boasts deep expertise in molecular biology, bioinformatics, and Next Generation Sequencing (NGS), fostering a dynamic and fast-paced work environment that offers significant opportunities for impactful contributions and rapid professional growth.